Final results from the Betaseron (interferon β-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events
Authors:
Open Access
Abstract
Objective Women with multiple sclerosis are often diagnosed and treated during their reproductive years. Limited data are available on the safety of treatment during pregnancy. The Betaseron Pregnancy Registry prospectively monitored women exposed to interferon β-1b (IFNβ-1b) during pregnancy to estimate the rates of birth defects, spontaneous abortions (SABs) and other negative outcomes in this population. Design From 2006 to 2011, this observational registry enrolled women exposed prior to conception or during pregnancy (but prior to or without abnormalities on prenatal screening). Follow-up continued from enrolment through the 4-month paediatric visit. Setting Patients in the USA who met these criteria were enrolled in the registry. Results The registry enrolled 99 pregnant women; 3 were lost to follow-up. The earliest exposure to IFNβ-1b occurred during the first trimester for 95 pregnancies and in the third trimester for 1 pregnancy. There were 99 birth outcomes (3 twins), including 86 (86.9%) live births, 11 (11.1%) SABs and 2 (2%) stillbirths. Birth defects were reported in five (5.1%) cases. Rates of birth defects and SAB were not significantly different from population comparators. No developmental concerns were identified at the 4-month paediatric visit. Conclusions The small sample size limits the ability to draw definitive conclusions; however, there was no pattern to suggest increased negative outcomes with IFNβ-1b. Clinical trials registration number NCT00317564.Keywords
This publication has 18 references indexed in Scilit:
- EXPOSURE TO INTERFERON-β THERAPY IN EARLY PREGNANCY: A LITERATURE REVIEW OF PREGNANCY OUTCOMES IN WOMEN WITH MULTIPLE SCLEROSISJournal of Neurology, Neurosurgery & Psychiatry, 2012
- Disease-modifying drugs for multiple sclerosis in pregnancyNeurology, 2012
- Multiple sclerosis and pregnancy: experience from a nationwide database in GermanyTherapeutic Advances in Neurological Disorders, 2012
- Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosisNeurology, 2010
- Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational studyMultiple Sclerosis Journal, 2009
- Is in utero early-exposure to interferon beta a risk factor for pregnancy outcomes in multiple sclerosis?Journal of Neurology, 2008
- ErrataBirth Defects Research Part A: Clinical and Molecular Teratology, 2008
- The burden of multiple sclerosis: A community health surveyHealth and Quality of Life Outcomes, 2008
- The reproductive effects of beta interferon therapy in pregnancyNeurology, 2005
- Birth defect classification by organ system: a novel approach to heighten teratogenic signalling in a pregnancy registryPharmacoepidemiology and Drug Safety, 2002